Header graphic for print
Class Action Blog Tp provide current legal information relating to class action lawsuits, including consumer fraud, consumer protection, securities and antitrust class actions

Your Prostate Supplement May Be Deceptively Advertised

As men get older, one of the greatest health risks they face is prostrate enlargement (also known as “benign prostatic hyperplasia” of BPH).  Not surprisingly, many men look to supplements to maintain a healthy prostrate.  One such supplement is saw palmetto.  However, a recent study published in the Journal of the American Medical Association concluded that saw palmetto is no better than a placebo at reducing or otherwise improving prostate enlargement.  Moreover, it appears that some saw palmetto supplements are deceptively advertised.  For example, Prostavar RX is labeled as a “BPH Inhibitor”, but the FDA does not approve of labels that claim to prevent, or inhibit, diseases like BPH.  Prostavar RX also claims that it is clinically proven to reduce prostrate inflammation in 94% of men; an unlikely claim, particularly as no study is cited. 

 Aother supplement with labeling issues is Prostate Power Rx.  A recent report from Consumer Lab reports that Prostate Power Rx only contains half of the saw palmetto markers expected, indicating either that the supplement does not contain all of the saw palmetto represented, or that the supplement used is of poor quality. 

If you or someone you know purchased any of these products, please contact us to discuss your legal options.